{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:09:52Z","timestamp":1784124592304,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Higher Education, Scientific Research, and Technology","award":["UR12SP34 and"],"award-info":[{"award-number":["UR12SP34 and"]}]},{"name":"Ministry of Higher Education, Scientific Research, and Technology","award":["LR18ES47) Tunisia."],"award-info":[{"award-number":["LR18ES47) Tunisia."]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.imlet.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T11:09:43Z","timestamp":1602068983000},"page":"70-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["IL-18 variant increases risk of enhanced HBV DNA replication in chronic hepatitis"],"prefix":"10.1016","volume":"228","author":[{"given":"Walid","family":"Ben Selma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Alibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ali","family":"Smach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afef","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalel","family":"Boukadida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2020.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2020.10.002_bib0010","series-title":"Licence: CC BY-NC-SA 3.0 IGO","first-page":"8","article-title":"Global hepatitis report Geneva","author":"WHO","year":"2017"},{"key":"10.1016\/j.imlet.2020.10.002_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"European association for the study of the LiverEASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.trim.2005.03.006","article-title":"Host genetics and the outcome of hepatitis B viral infection","volume":"14","author":"Frodsham","year":"2005","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2020.06.004","article-title":"Interaction analysis of IL-12A and IL-12B gene variants with chronic hepatitis B infection in Tunisian patients","volume":"225","author":"Ben Selma","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2020.10.002_bib0030","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/jvh.12749","article-title":"Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV\u2010related liver complications: a study in a Saudi Arabian","volume":"24","author":"Al-Qahtani","year":"2017","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.imlet.2020.10.002_bib0035","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3389\/fgene.2019.00696","article-title":"Host genetic determinants of hepatitis B virus infection","volume":"13","author":"Zhang","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.imlet.2020.10.002_bib0040","article-title":"Associations of genetic polymorphisms in CTLA-4 and IL-18 with chronic liver diseases: evidence from a meta-analysis","author":"Zhang","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.imlet.2020.10.002_bib0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.meegid.2007.09.001","article-title":"Oral B. Association of TNF-alpha -308 polymorphism with the outcome of hepatitis B virus infection in Turkey","volume":"8","author":"Basturk","year":"2008","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jvh.12817","article-title":"Role of functional IFNL4, IFNLR1, IFNA, IFNAR2 polymorphisms in hepatitis B virus\u2010related liver disease in Han Chinese population","volume":"25","author":"Ma","year":"2018","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.imlet.2020.10.002_bib0055","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/JVI.73.3.2401-2409.1999","article-title":"Interleukin-18 protects mice against acute Herpes simplex virus type 1 infection","volume":"73","author":"Fujioka","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0060","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1128\/JVI.77.18.9960-9968.2003","article-title":"Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity","volume":"77","author":"Reading","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0528.2002.017418.x","article-title":"Pathophysiological roles of interleukin-18 inflammatory liver diseases","volume":"174","author":"Tsutsui","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2020.10.002_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/meth.1999.0837","article-title":"Interleukin-18","volume":"19","author":"Dinarello","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.imlet.2020.10.002_bib0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1067\/mai.2003.43","article-title":"Polymorphisms in the IL 18 gene are associated with specific sensitization to common allergens and allergic rhinitis","volume":"111","author":"Kruse","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1146\/annurev.biochem.66.1.807","article-title":"Transcriptional regulation by cyclic AMP","volume":"66","author":"Montminy","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.imlet.2020.10.002_bib0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00407-0","article-title":"Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation","volume":"112","author":"Giedraitis","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2222.2006.02424.x","article-title":"The common G-allele of interleukin-18 single-nucleotide polymorphism is a genetic risk factor for atopic asthma. The SAPALDIA Cohort Study","volume":"36","author":"Imboden","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.imlet.2020.10.002_bib0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.104.519702","article-title":"Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease","volume":"112","author":"Tiret","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.imlet.2020.10.002_bib0100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbi.2007.10.001","article-title":"Interleukin-18 produced by peripheral blood cells is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"22","author":"Boss\u00f9","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imlet.2020.10.002_bib0105","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s10875-009-9302-z","article-title":"Interleukin 18 promoter variants (-137 G&C and 607C&A) in patients with chronic hepatitis C: association with treatment response","volume":"29","author":"Haas","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0110","article-title":"Associations of polymorphisms in IL-6 and IL-18 with tuberculosis: evidence from a meta-analysis","volume":"139","author":"He","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.imlet.2020.10.002_bib0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwn359","article-title":"Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies","volume":"169","author":"Santiago","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both Th1 and Th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4254\/wjh.v4.i3.105","article-title":"Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection","volume":"4","author":"Li","year":"2012","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1399-0039.2007.00865.x","article-title":"Association of interleukin-18 gene polymorphism (-607A\/A genotype) with susceptibility to chronic hepatitis B virus infection","volume":"70","author":"Hirankarn","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.imlet.2020.10.002_bib0135","article-title":"Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population","volume":"11","author":"Zhang","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0140","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/jmv.24225","article-title":"IL-18, TNF, and IFN-\u03b3 alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury","volume":"87","author":"Ferreira","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0145","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.19879","article-title":"Interleukin 18 gene promoter polymorphisms and susceptibility to chronic hepatitis B infection: a review study","volume":"14","author":"Motavaf","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.imlet.2020.10.002_bib0150","doi-asserted-by":"crossref","first-page":"G565","DOI":"10.1152\/ajpgi.00058.2011","article-title":"Dual effects of interleukin-18: inhibiting hepatitis B virus replication in HepG2.2.15 cells and promoting hepatoma cell metastasis","volume":"301","author":"Zhang","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0155","doi-asserted-by":"crossref","first-page":"10702","DOI":"10.1128\/JVI.76.21.10702-10707.2002","article-title":"Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice","volume":"76","author":"Kimura","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0160","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1128\/JVI.76.11.5646-5653.2002","article-title":"Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures","volume":"76","author":"Pasquetto","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0165","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1073\/pnas.0504273102","article-title":"Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids","volume":"102","author":"Wieland","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.imlet.2020.10.002_bib0170","first-page":"105","article-title":"Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis","volume":"22","author":"Zhou","year":"2005","journal-title":"Sarcoidosis. Vasc. Diffuse. Lung Dis."},{"key":"10.1016\/j.imlet.2020.10.002_bib0175","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/jmv.24225","article-title":"IL-18, TNF, and IFN-\u03b3 alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury","volume":"87","author":"Ferreira","year":"2015","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trsl.2008.11.008","article-title":"Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease","author":"Migita","year":"2009","journal-title":"Transl. Res."},{"key":"10.1016\/j.imlet.2020.10.002_bib0185","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/ar1930","article-title":"A promoter haplotype of the interleukin-18 gene is associated with juvenile idiopathic arthritis in the Japanese population","volume":"8","author":"Sugiura","year":"2006","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.imlet.2020.10.002_bib0190","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jmv.21079","article-title":"Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection","volume":"80","author":"Bouzgarrou","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0195","doi-asserted-by":"crossref","first-page":"81350","DOI":"10.18632\/oncotarget.18531","article-title":"IL-18 polymorphisms contribute to hepatitis B virusrelated cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study","volume":"17","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.imlet.2020.10.002_bib0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/iub.1714","article-title":"Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection","volume":"70","author":"Bakr","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.imlet.2020.10.002_bib0205","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/379591a0","article-title":"A newly defined interleukin-1?","volume":"379","author":"Bazan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2020.10.002_bib0210","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jlb.63.6.658","article-title":"Overview of interleukin-18","volume":"63","author":"Dinarello","year":"1998","journal-title":"J. Leuk. Biol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0952-7915(98)80163-5","article-title":"Regulation of interferon-\u03b3 production by IL-12 and IL-18","volume":"10","author":"Okamura","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2020.10.002_bib0220","doi-asserted-by":"crossref","first-page":"25737","DOI":"10.1074\/jbc.272.41.25737","article-title":"Purification and characterization of the human Interleukin-18 (hIL-18) receptor","volume":"272","author":"Torigoe","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2020.10.002_bib0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-\u03b3 inducing factor mediated by interleukin-1\u03b2 converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:39:13Z","timestamp":1759045153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247820303989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":45,"alternative-id":["S0165247820303989"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2020.10.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-18 variant increases risk of enhanced HBV DNA replication in chronic hepatitis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}]}}